429. Cytoreductive surgery with intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin

Background: Peritoneal carcinomatosis (PC) of colorectal origin, being detected in 10–15% of patients at the time of primary cancer resection, and the first recurrence occurs in the peritoneum in 50% of patients after curative surgery. In 10–35% of all patients with recurrent disease, tumor recurrence is confined to the peritoneal surface only.